B-type natriuretic peptide and survival in hypertrophic cardiomyopathy

Journal of the American College of Cardiology

Volumn 61, Issue 24, 2013, Pages 2456-2460

  Geske, Jeffrey B ^a   McKie, Paul M ^a   Ommen, Steve R ^a   Sorajja, Paul ^a  

^a MAYO CLINIC   (United States)

Author keywords

B type natriuretic peptide hypertrophic cardiomyopathy survival

Indexed keywords

BRAIN NATRIURETIC PEPTIDE;

ADULT; ARTICLE; CARDIOPULMONARY EXERCISE; CAUSE OF DEATH; CLINICAL ASSESSMENT; COHORT ANALYSIS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE ASSOCIATION; ECHOCARDIOGRAPHY; EXERCISE; FEMALE; FOLLOW UP; HEART SURGERY; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MORBIDITY; NEW YORK HEART ASSOCIATION CLASS; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; PROTEIN BLOOD LEVEL; SEPTAL REDUCTION THERAPY; SURVIVAL;

ADULT; AGED; CARDIOMYOPATHY, HYPERTROPHIC; COHORT STUDIES; DISEASE-FREE SURVIVAL; ECHOCARDIOGRAPHY; FEMALE; GENE EXPRESSION REGULATION; HUMANS; IMMUNOASSAY; MALE; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; REGRESSION ANALYSIS; TIME FACTORS; TREATMENT OUTCOME;

EID: 84878896522     PISSN: 07351097     EISSN: 15583597     Source Type: Journal    
DOI: 10.1016/j.jacc.2013.04.004     Document Type: Article

References (26)

1. S.R. Ommen, and R.A. Nishimura Hypertrophic cardiomyopathy Curr Probl Cardiol 29 2004 239 291
2. C. Hall Essential biochemistry and physiology of (NT-pro)BNP Eur J Heart Fail 6 2004 257 260
3. I.L. Gerber, R.A. Stewart, and M.E. Legget Increased plasma natriuretic peptide levels reflect symptom onset in aortic stenosis Circulation 107 2003 1884 1890
4. D.A. Morrow, J.A. de Lemos, and M.S. Sabatine Evaluation of B-type natriuretic peptide for risk assessment in unstable angina/non-ST-elevation myocardial infarction: B-type natriuretic peptide and prognosis in TACTICS-TIMI 18 J Am Coll Cardiol 41 2003 1264 1272
5. A. Rossi, M. Enriquez-Sarano, J.C. Burnett Jr., A. Lerman, M.D. Abel, and J.B. Seward Natriuretic peptide levels in atrial fibrillation: a prospective hormonal and Doppler-echocardiographic study J Am Coll Cardiol 35 2000 1256 1262
6. A.S. Maisel, P. Krishnaswamy, and R.M. Nowak Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure N Engl J Med 347 2002 161 167
7. R.W. Troughton, C.M. Frampton, T.G. Yandle, E.A. Espiner, M.G. Nicholls, and A.M. Richards Treatment of heart failure guided by plasma aminoterminal brain natriuretic peptide (N-BNP) concentrations Lancet 355 2000 1126 1130
8. B. Mutlu, F. Bayrak, G. Kahveci, M. Degertekin, E. Eroglu, and Y. Basaran Usefulness of N-terminal pro-B-type natriuretic peptide to predict clinical course in patients with hypertrophic cardiomyopathy Am J Cardiol 98 2006 1504 1506
9. P. Richardson, W. McKenna, and M. Bristow Report of the 1995 World Health Organization/International Society and Federation of Cardiology Task Force on the Definition and Classification of Cardiomyopathies Circulation 93 1996 841 842
10. B.J. Maron, and S.E. Epstein Hypertrophic cardiomyopathy: a discussion of nomenclature Am J Cardiol 43 1979 1242 1244
11. L.K. Morrison, A. Harrison, P. Krishnaswamy, R. Kazanegra, P. Clopton, and A. Maisel Utility of a rapid B-natriuretic peptide assay in differentiating congestive heart failure from lung disease in patients presenting with dyspnea J Am Coll Cardiol 39 2002 202 209
12. J.B. Geske, P. Sorajja, R.A. Nishimura, and S.R. Ommen Evaluation of left ventricular filling pressures by Doppler echocardiography in patients with hypertrophic cardiomyopathy: correlation with direct left atrial pressure measurement at cardiac catheterization Circulation 116 2007 2702 2708
13. H. Daida, T.G. Allison, R.W. Squires, T.D. Miller, and G.T. Gau Peak exercise blood pressure stratified by age and gender in apparently healthy subjects Mayo Clin Proc 71 1996 445 452
14. E. Arteaga, A.Q. Araujo, P. Buck, B.M. Ianni, R. Rabello, and C. Mady Plasma amino-terminal pro-B-type natriuretic peptide quantification in hypertrophic cardiomyopathy Am Heart J 150 2005 1228 1232
15. J. Binder, S.R. Ommen, H.H. Chen, M.J. Ackerman, A.J. Tajik, and A.S. Jaffe Usefulness of brain natriuretic peptide levels in the clinical evaluation of patients with hypertrophic cardiomyopathy Am J Cardiol 100 2007 712 714
16. J.P. Kaski, M.T. Tome-Esteban, and S. Mead-Regan B-type natriuretic peptide predicts disease severity in children with hypertrophic cardiomyopathy Heart 94 2008 1307 1311
17. S.W. Kim, S.W. Park, and S.H. Lim Amount of left ventricular hypertrophy determines the plasma N-terminal pro-brain natriuretic peptide level in patients with hypertrophic cardiomyopathy and normal left ventricular ejection fraction Clin Cardiol 29 2006 155 160
18. K. Ogino, K. Ogura, and T. Kinugawa Neurohumoral profiles in patients with hypertrophic cardiomyopathy: differences to hypertensive left ventricular hypertrophy Circ J 68 2004 444 450
19. F.K. Panou, V.K. Kotseroglou, and J.A. Lakoumentas Significance of brain natriuretic peptide in the evaluation of symptoms and the degree of left ventricular diastolic dysfunction in patients with hypertrophic cardiomyopathy Hellenic J Cardiol 47 2006 344 351
20. B.J. Maron, V.N. Tholakanahalli, and A.G. Zenovich Usefulness of B-type natriuretic peptide assay in the assessment of symptomatic state in hypertrophic cardiomyopathy Circulation 109 2004 984 989
21. C. Briguori, S. Betocchi, and F. Manganelli Determinants and clinical significance of natriuretic peptides and hypertrophic cardiomyopathy Eur Heart J 22 2001 1328 1336
22. H. Kitaoka, T. Kubo, and M. Okawa Utility of tissue Doppler imaging to predict exercise capacity in hypertrophic cardiomyopathy: comparison with B-type natriuretic peptide J Cardiol 53 2009 361 367
23. J.B. Geske, P. Sorajja, S.R. Ommen, and R.A. Nishimura Variability of left ventricular outflow tract gradient during cardiac catheterization in patients with hypertrophic cardiomyopathy J Am Coll Cardiol Intv 4 2011 704 709
24. J.B. Geske, P. Sorajja, S.R. Ommen, and R.A. Nishimura Left ventricular outflow tract gradient variability in hypertrophic cardiomyopathy Clin Cardiol 32 2009 397 402
25. P. Sorajja, R.A. Nishimura, and B.J. Gersh Outcome of mildly symptomatic or asymptomatic obstructive hypertrophic cardiomyopathy: a long-term follow-up study J Am Coll Cardiol 54 2009 234 241
26. P. Sorajja, S.R. Ommen, and D.R. Holmes Jr. Survival after alcohol septal ablation for obstructive hypertrophic cardiomyopathy Circulation 126 2012 2374 2380